This is achieved through modulation of signaling pathways, including the suppression of the nuclear factor kappa B (NF-κB) pathway and activation of the PPAR pathway, thereby influencing tumor cell life cycles [44,45]. The gene discussed is PPARA; the disease is neoplasm.